Equity Overview
Price & Market Data
Price: $11.75
Daily Change: +$0.10 / 0.85%
Daily Range: $11.50 - $11.96
Market Cap: $308,443,360
Daily Volume: 50,226
Performance Metrics
1 Week: 7.50%
1 Month: -15.10%
3 Months: -13.22%
6 Months: %
1 Year: 47.24%
YTD: -6.97%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country:
Details
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.